Biotech 2050 Podcast
11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics
almost 4 years ago
10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines
almost 5 years ago
9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation
almost 5 years ago
8. Dr. Florian Wegener, Co-Founder and CEO of ZAGENO
almost 5 years ago
7. Raman Sehgal, Founder and Global President of Ramarketing
almost 5 years ago
6. Kevin J. Bittorf, PhD: Consultant and Founder, Simulation LLC
almost 5 years ago
5. Jon Hennek: Systems Innovation Team Co-Lead at Indigo Ag
almost 5 years ago
4. Sven Karlsson: Co-founder, COO and CBO of Platelet BioGenesis
almost 5 years ago
3. Dr. Jo Viney: Co-Founder, President and CSO of Pandion Therapeutics
almost 5 years ago
2. John Keilty: Chief Data Sciences Officer at Decibel Therapeutics
almost 5 years ago